Physician profile
Meena Devalla
NPI 1497765358
$1,437.78
in general payments reported to CMS, 2019-2025
17 companies · $36.42 in 2025
The $36.42 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $417 · 2020: $206 · 2021: $208 · 2022: $145 · 2023: $65.09 · 2024: $360 · 2025: $36.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $461.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $305.61 | 2019-2021 | |
| Hologic Sales and Service, LLC | $197.57 | 2021-2024 | Omni Hysteroscope |
| Abbvie INC. | $150.91 | 2019-2023 | Liletta |
| Exeltis, USA INC. | $109.73 | 2024-2025 | Slynd |
| Astellas Pharma US INC | $109.19 | 2023-2024 | Veozah |
| Roche Diagnostics Corporation | $89.48 | 2019-2020 | |
| Allergan, INC. | $65.60 | 2019-2020 | |
| Agile Therapeutics, INC. | $59.61 | 2022-2023 | Twirla |
| Merck Sharp & Dohme LLC | $57.82 | 2019 | |
| Mylan Pharmaceuticals INC. | $55.42 | 2021-2022 | |
| Pfizer INC. | $52.02 | 2020-2024 | |
| Kerecis Limited | $50.46 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Organon LLC | $49.36 | 2022-2024 | Nexplanon |
| Daiichi Sankyo INC. | $37.67 | 2019-2020 | |
| Dysis Medical, INC. | $18.37 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $14.70 | 2019 | |
| Glaxosmithkline, LLC. | $14.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meena Devalla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.